Aspen Aerogels (NYSE:ASPN) Upgraded to “Sell” at StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN) to a sell rating in a research report report published on Wednesday morning.

Other analysts also recently issued research reports about the stock. Piper Sandler decreased their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Craig Hallum decreased their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Barclays cut their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. Roth Mkm reduced their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Finally, Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.44.

Aspen Aerogels Stock Down 1.4 %

Shares of ASPN opened at $8.04 on Wednesday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The business has a fifty day moving average of $11.75 and a 200 day moving average of $18.15. The company has a market cap of $659.27 million, a PE ratio of 50.22 and a beta of 2.14. Aspen Aerogels has a 52-week low of $7.96 and a 52-week high of $33.15.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, sell-side analysts expect that Aspen Aerogels will post 0.22 EPS for the current year.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in ASPN. Millennium Management LLC grew its holdings in Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock worth $19,270,000 after acquiring an additional 1,588,632 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $13,122,000. Alyeska Investment Group L.P. bought a new position in shares of Aspen Aerogels during the fourth quarter valued at approximately $9,504,000. Dendur Capital LP bought a new position in shares of Aspen Aerogels during the fourth quarter valued at approximately $9,207,000. Finally, FMR LLC increased its holdings in Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after buying an additional 773,647 shares during the period. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.